Amg 181

DRUG2 trials

Sponsors

Amgen

Conditions

Crohn's DiseaseUlcerative Colitis

Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

TerminatedNCT01164904

AmgenUlcerative Colitis

Start: 2010-07-31End: 2013-03-31Updated: 2013-07-25

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

CompletedNCT01290042

AmgenCrohn's Disease, Ulcerative Colitis

Start: 2011-02-28End: 2014-05-31Updated: 2015-03-17